LAWSUITS NEWS & LEGAL INFORMATION
Merck to Settle NuvaRing Lawsuits for $100M
This is a settlement for the NuvaRing lawsuit.
New York, NY: Hundreds of NuvaRing lawsuits are about to be settled by Merck & Co. The New Jersey based pharmaceutical company has agreed to pay $100 million to settle the lawsuits, and end allegations it downplayed serious health risks associated with the contraceptive device.
The agreement will settle cases in both federal and state courts, with plaintiffs expected to receive about $58,000 per complaint.
Currently, there are over 1,700 NuvaRing personal injury and defective product lawsuits pending against Merck. They allege the company failed to adequately warn women about the potential increased risk for developing dangerous blood clots known as venous thromboembolism associated with the device. Plaintiffs are seeking damages for a range of injuries allegedly caused by the birth control device, including heart attack, stroke and sudden death.
Available in the US since 2001, NuvaRing is one of several contraceptive products that have been linked to an increased risk of developing blood clots that can cause strokes and heart attacks. As of March 2012, approximately 12,000 lawsuits had been brought against Bayer HealthCare Pharmaceuticals, Inc., the manufacturer of Yasmin, Yaz, Beyaz and Safyral, alleging an increased risk of blood clots (deep vein thrombosis (DVT), pulmonary embolism (PE)) and gallbladder problems. Ocella, the generic version of Yasmin, is also associated with serious side effects, some of which are potentially fatal. In 2013, Bayer AG paid $1.6 billion to settle those lawsuits. If the $100 million figure Merck is supposedly to pay proves accurate, it will be a much smaller settlement.
Published on Feb-10-14
The agreement will settle cases in both federal and state courts, with plaintiffs expected to receive about $58,000 per complaint.
Currently, there are over 1,700 NuvaRing personal injury and defective product lawsuits pending against Merck. They allege the company failed to adequately warn women about the potential increased risk for developing dangerous blood clots known as venous thromboembolism associated with the device. Plaintiffs are seeking damages for a range of injuries allegedly caused by the birth control device, including heart attack, stroke and sudden death.
Available in the US since 2001, NuvaRing is one of several contraceptive products that have been linked to an increased risk of developing blood clots that can cause strokes and heart attacks. As of March 2012, approximately 12,000 lawsuits had been brought against Bayer HealthCare Pharmaceuticals, Inc., the manufacturer of Yasmin, Yaz, Beyaz and Safyral, alleging an increased risk of blood clots (deep vein thrombosis (DVT), pulmonary embolism (PE)) and gallbladder problems. Ocella, the generic version of Yasmin, is also associated with serious side effects, some of which are potentially fatal. In 2013, Bayer AG paid $1.6 billion to settle those lawsuits. If the $100 million figure Merck is supposedly to pay proves accurate, it will be a much smaller settlement.
Legal Help
If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please fill in our form.Published on Feb-10-14
READ MORE Defective Products Settlements and Legal News
READ MORE Drugs/Medical Settlements and Legal News
READ MORE Personal Injury Settlements and Legal News